Clinical Trials
11
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
- Conditions
- Heart Failure With Reduced Ejection Fraction (HFrEF)Dilated Cardiomyopathy
- Interventions
- Device: AccuCinch Ventricular Restoration SystemDrug: Guideline-Directed Medical Therapy
- First Posted Date
- 2020-04-02
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Ancora Heart, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT04331769
- Locations
- 🇺🇸
Grandview Medical Group Research, LLC, Birmingham, Alabama, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation
- Conditions
- Cardiomyopathy, DilatedHeart Failure
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Ancora Heart, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT03560167
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸Piedmont Heart, Atlanta, Georgia, United States
🇺🇸Emory University, Atlanta, Georgia, United States
Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction
- Conditions
- Heart FailureCardiomyopathy, Dilated
- First Posted Date
- 2018-05-23
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Ancora Heart, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT03533517
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸University of Louisville, Louisville, Kentucky, United States
Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study
- Conditions
- Heart FailureCardiomyopathies
- First Posted Date
- 2017-06-12
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Ancora Heart, Inc.
- Target Recruit Count
- 132
- Registration Number
- NCT03183895
- Locations
- 🇧🇾
Republican Scientific and Practical Centre of Cardiology, Minsk, Belarus
🇧🇪Onze Lieve Vrouwziekenhuis, Aalst, Aaslt, Belgium
🇧🇪AZ Sint-Jan Brugge, Brugge, Belgium
The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study
- Conditions
- Heart FailureCardiomyopathiesMitral Valve Insufficiency
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Ancora Heart, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT02806570
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸University of Louisville, Louisville, Kentucky, United States
🇺🇸Minneapolis Heart Foundation Institute, Minneapolis, Minnesota, United States
- Prev
- 1
- 2
- Next